NASDAQ:AMGN

Amgen SEC Filings & 10K Form

$219.38
+2.02 (+0.93 %)
(As of 09/17/2021 04:00 PM ET)
Add
Compare
Today's Range
$215.87
$219.88
50-Day Range
$213.75
$247.96
52-Week Range
$210.28
$276.69
Volume5.66 million shs
Average Volume2.60 million shs
Market Capitalization$124.58 billion
P/E Ratio22.32
Dividend Yield3.24%
Beta0.68

Amgen (NASDAQ:AMGN) SEC Filings

DateFilerForm TypeView
09/13/2021
6:28 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/13/2021
6:27 PM
Amgen (Reporting)
BeiGene, Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
6:00 PM
Amgen (Issuer)
Kullman Ellen Jamison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
5:59 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
5:56 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2021
4:03 PM
Amgen (Filer)
Form 424B2
08/05/2021
7:31 AM
Amgen (Filer)
Form 424B3
07/30/2021
5:14 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/01/2021
5:08 AM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2021
6:22 PM
Amgen (Issuer)
Druker Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:24 PM
Amgen (Issuer)
Williams R Sanders (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:23 PM
Amgen (Issuer)
SUGAR RONALD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:22 PM
Amgen (Issuer)
MILES AMY E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:20 PM
Amgen (Issuer)
Kullman Ellen Jamison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:19 PM
Amgen (Issuer)
Jacks Tyler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:18 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:17 PM
Amgen (Issuer)
Garland Greg C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:15 PM
Amgen (Issuer)
ECKERT ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:14 PM
Amgen (Issuer)
Austin Wanda M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2021
7:11 PM
Amgen (Issuer)
SUGAR RONALD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2021
7:10 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2021
5:38 PM
Amgen (Issuer)
Williams R Sanders (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:44 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:41 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:38 PM
Amgen (Issuer)
Piacquad David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:35 PM
Amgen (Issuer)
Louie Linda H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:31 PM
Amgen (Issuer)
Johnston Lori A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:21 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:18 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:15 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:12 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2021
8:44 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2021
8:41 PM
Amgen (Issuer)
Kullman Ellen Jamison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2021
8:38 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2021
7:20 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2021
7:17 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2021
7:14 PM
Amgen (Issuer)
Piacquad David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2021
7:11 PM
Amgen (Issuer)
Louie Linda H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2021
7:08 PM
Amgen (Issuer)
Amgen (Issuer)
Johnston Lori A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2021
7:05 PM
Amgen (Issuer)
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2021
7:01 PM
Amgen (Issuer)
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2021
6:55 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2021
7:45 AM
Amgen (Filer)
Form DEFA14A
04/27/2021
3:10 PM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2021
7:39 AM
Amgen (Filed by)
FIVE PRIME THERAPEUTICS, INC. (Subject)
Form SC TO-T/A
04/16/2021
7:32 AM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2021
11:15 PM
Amgen (Filer)
Form EFFECT
04/15/2021
5:27 PM
Amgen (Issuer)
SUGAR RONALD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2021
7:45 AM
Amgen (Filer)
Form DEFA14A
04/08/2021
7:02 AM
Amgen (Filed by)
FIVE PRIME THERAPEUTICS, INC. (Subject)
Form SC TO-T/A
04/06/2021
7:35 AM
Amgen (Filer)
Form DEFA14A
04/06/2021
7:30 AM
Amgen (Filer)
Form DEF 14A
04/06/2021
7:01 AM
Amgen (Filed by)
FIVE PRIME THERAPEUTICS, INC. (Subject)
Form SC TO-T/A
03/22/2021
5:36 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2021
5:34 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2021
5:33 PM
Amgen (Issuer)
Piacquad David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2021
5:31 PM
Amgen (Issuer)
Louie Linda H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2021
5:30 PM
Amgen (Issuer)
Johnston Lori A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2021
5:28 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2021
5:26 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2021
5:24 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2021
5:21 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2021
4:08 PM
Amgen (Filed by)
FIVE PRIME THERAPEUTICS, INC. (Subject)
Form SC TO-T/A
03/18/2021
7:01 AM
Amgen (Filed by)
FIVE PRIME THERAPEUTICS, INC. (Subject)
Form SC TO-T
03/10/2021
5:07 PM
Amgen (Issuer)
SUGAR RONALD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
3:19 PM
Amgen (Filed by)
FIVE PRIME THERAPEUTICS, INC. (Subject)
Form SC TO-C
03/04/2021
7:37 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
7:35 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
7:33 PM
Amgen (Issuer)
Piacquad David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
7:30 PM
Amgen (Issuer)
Louie Linda H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
7:29 PM
Amgen (Issuer)
Johnston Lori A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
7:27 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
7:25 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
7:22 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
7:20 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
4:23 PM
Amgen (Filed by)
FIVE PRIME THERAPEUTICS, INC. (Subject)
Form SC TO-C
03/04/2021
7:40 AM
Amgen (Filed by)
FIVE PRIME THERAPEUTICS, INC. (Subject)
Form SC TO-C
03/04/2021
7:39 AM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2021
6:27 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
7:59 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
2:46 PM
Amgen (Subject)
Capital Research Global Investors (Filed by)
Form SC 13G/A
02/10/2021
6:40 PM
Amgen (Issuer)
SUGAR RONALD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2021
9:30 AM
Amgen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/09/2021
7:03 PM
Amgen (Issuer)
Johnston Lori A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
3:45 PM
Amgen (Filer)
Form S-4
Registration statement under Securities Act of 1933  
02/08/2021
7:36 PM
Amgen (Issuer)
Williams R Sanders (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
7:32 PM
Amgen (Issuer)
Kullman Ellen Jamison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2021
7:06 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2021
9:57 AM
Amgen (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/02/2021
3:13 PM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2021
5:25 PM
Amgen (Issuer)
SUGAR RONALD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2020
3:17 PM
Amgen (Filer)
Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities  
12/28/2020
3:12 PM
Amgen (Filer)
Form CERT
12/28/2020
3:05 PM
Amgen (Filer)
Form 8-A12B
12/18/2020
8:25 PM
Amgen (Reporting)
BeiGene, Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
8:18 PM
Amgen (Reporting)
BeiGene, Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2020
5:32 PM
Amgen (Issuer)
Williams R Sanders (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
6:06 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
6:02 PM
Amgen (Issuer)
Louie Linda H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
6:00 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 9/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.